Prenosis Inc: Valuation, Funding & Investors
Prenosis, Inc. is a biology-based technology company that develops integrated diagnostics and therapeutics for critical care conditions. The company leverages deep data and artificial intelligence through its Immunix platform to build AI-driven diagnostic tools and companion therapeutics, including the FDA-authorized Sepsis ImmunoScore, to enable precision medicine for sepsis, ARDS, AKI, pneumonia, and acute heart failure.
Leadership & Board
- Current Number of Employees
- 42
- Current LinkedIn Followers
- 4,669
Latest Estimated Valuation
- Total Amount Raised
- $20M
- Total Funding Rounds
- 1
- Latest Funding Amount
- $20M
- Latest Funding Round
- Series A
Employee Trend
Prenosis Inc had 42 employees as of November 2, 2026. The number of employees increased by 0 (0.00%) week-over-week.
Social Trend
Prenosis Inc had 4,669 followers as of November 2, 2026. The number of followers increased by 17 (0.37%) week-over-week.
Funding Round
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| Jan 29, 2026 | Series A | $20.00M | ― |
Investors
| Investor Name | Funding Round |
|---|---|
| Labcorp Venture Fund | Series A |
| UC Investments | Series A |
| Global Health Investment Corporation | Series A |
| PACE Healthcare Capital | Series A |
| UCI Health Ventures | Series A |
| Illinois Department of Commerce and Economic Opportunity | Series A |
| Carle Health | Series A |
Similar Companies
A snapshot of private companies similar to Prenosis Inc, helping you discover and navigate related company profiles.
Related News and Analysis
